Examples of 'further or additional' in a sentence
Meaning of "further or additional"
further or additional - This phrase is used to indicate the availability or need for more, extra, or supplementary items, information, actions, or resources
How to use "further or additional" in a sentence
Basic
Advanced
further or additional
In further or additional embodiments the cell is a mammalian cell.
This moiety may be trimmed further or additional residues added.
In further or additional embodiments the contacting occurs within a cell.
In further or additional embodiments the enzyme is essentially completely inhibited.
Further or additional.
In further or additional embodiments the compound of formula I is administered three times per day.
In further or additional embodiments the compound of formula I is administered four times per day.
In further or additional embodiments the MEK enzyme is MEK kinase.
In further or additional embodiments the compound of formula I is administered twice daily.
In further or additional embodiments, the cancer is glioblastoma.
In further or additional embodiments, the mammal is human.
In further or additional embodiments, the cancer is mesothelioma.
In further or additional embodiments, the tumor is eradicated.
In further or additional embodiments, the individual is a human.
In further or additional cases, the mammal is human.
See also
In further or additional embodiments, the cancer is pancreatic cancer.
In further or additional embodiments, the cancer is colorectal cancer.
In further or additional embodiments, the cancer is renal cancer.
In further or additional instances, the acid is hydrobromic acid.
In further or additional embodiments, the cancer is myeloid leukemia.
In further or additional embodiments, the cancer is prostate cancer.
In further or additional embodiments, the cancer is breast cancer.
In further or additional embodiments, such derivatizations occur at a pH of about 5.
In further or additional embodiments, the cancer is ovarian cancer.
In further or additional embodiments, the cancer is follicular lymphona.
In further or additional embodiments, the cancer is follicular lymphoma.
In further or additional embodiments, the proliferative disease is a hyperproliferative disease.
In further or additional embodiments, the effect is inhibition inflammatory diseases.
In further or additional embodiments, the effect is inhibition of immunological diseases.
In further or additional embodiments, the cancer is brain cancer or adrenocortical carcinoma.
In further or additional embodiments, the cancer is small cell line cancer.
In further or additional embodiments, essentially all of the cancer cells are degraded.
In further or additional embodiments, the tissue or organ is blood, serum or plasma.
In further or additional embodiments, the blood disorder is polycythemia or myeloid metaplasia.
In further or additional cases the metabolite has a structure selected from,.
In further or additional embodiments, essentially all of the cancer cells are killed.
In further or additional embodiments, the therapeutic agent is taxol, bortezomib or both.
In further or additional cases, the blood disorder is polycythemia or myeloid metaplasia.
In further or additional embodiments, the growth of the cancer cells is inhibited.
In further or additional embodiments the metabolite has a structure selected from,.
In further or additional embodiments, scyllo-inositol is administered three times per day.
In further or additional embodiments, the composition is administered with at least one therapeutic agent.
In further or additional embodiments, the therapeutic agent is selected from taxol, bortezomib or both.
In further or additional embodiments are active metabolites of non-naturally encoded amino acid polypeptides.
In further or additional cases, the pharmaceutical composition further comprises at least one therapeutic agent.
In further or additional embodiments, the pharmaceutical composition further comprises a pharmaceutical carrier, excipient and / or adjuvant.
In further or additional embodiments, the emulsions contain sweetening agents, flavoring agents, preservatives and antioxidants.
In further or additional embodiments, the cancer is chronic lymphocytic B-leukemia.
In further or additional embodiments R1 is fused to the ring to which it is attached.
In further or additional embodiments, the MEK mediated disorder is a hyperproliferative disease.
You'll also be interested in:
Examples of using Further
Show more
Further measures will certainly have to be taken
I will be in touch with further instructions then
Further strategic actions to reduce maternal mortality
Examples of using Additional
Show more
Additional costs shall be incurred by the customer
Distributions and additional investments in the funds
Additional information could also be provided later
